
Drugs Having No Clinically Important Interactions with Aripiprazole (Abilify Maintena): Based on pharmacokinetic studies with oral aripiprazole, no dosage adjustment of Aripiprazole (Abilify Maintena) is required when administered concomitantly with famotidine, valproate, lithium, lorazepam [see PHARMACOLOGY under ACTIONS].
In addition, no dosage adjustment is necessary for substrates of CYP2D6 (e.g., dextromethorphan, fluoxetine, paroxetine, or venlafaxine), CYP2C9 (e.g., warfarin), CYP2C19 (e.g., omeprazole, warfarin), or CYP3A4 (e.g., dextromethorphan) when co-administered with Aripiprazole (Abilify Maintena). Additionally, no dosage adjustment is necessary for valproate, lithium, lamotrigine, lorazepam, or sertraline when co-administered with Aripiprazole (Abilify Maintena). [See PHARMACOLOGY under ACTIONS].